CAJPY vs HP: Which Is the Better Buy in 2026?
Last updated October 2026
Short answer
CAJPY is the larger of the two ($25.32B market cap): the incumbent the market prices for continued execution (13.60x forward earnings, beta 0.28). HP is the smaller challenger ($3.74B), actually pricier on forward earnings (24.05x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.
CAJPY vs HP: the tie-breaker metrics
Same yardstick, side by side (as of October 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | CAJPY | HP | What it tells you |
|---|---|---|---|
| Market cap | $25.32B | $3.74B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 13.60 | 24.05 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Beta | 0.28 | 0.69 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 72% of range | 58% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 1.17 | 1.45 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: CAJPY is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how CAJPY and HP affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CAJPY and HP share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CAJPY and HP exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Canon Inc. (CAJPY) do?
Canon Inc. is a Tokyo-headquartered manufacturer founded in 1937 that now runs four businesses. Printing (office multifunction printers, laser and inkjet printers, and commercial production presses) is still the largest, with ~¥2.49 trillion of 2025 sales, a little over half the group, and a ~10% segment margin built on toner, ink and service contracts. Imaging (EOS mirrorless and compact cameras, lenses and Axis network surveillance cameras) grew ~12.5% to ~¥1.05 trillion in 2025 at a ~16% margin and is now the most profitable growth engine. Medical (CT, MRI, ultrasound and X-ray systems through Canon Medical Systems, the former Toshiba Medical) brought in ~¥581 billion, and Industrial covers semiconductor lithography steppers, nanoimprint lithography and display manufacturing equipment. Its primary listing is on the Tokyo Stock Exchange under code 7751. Canon voluntarily delisted from the New York Stock Exchange in 2016, and US investors now hold it through the CAJPY American Depositary Receipt, which trades over the counter, with each ADR representing one ordinary share.
What does Helmerich & Payne (HP) do?
Helmerich & Payne, Inc. is one of the largest contract drilling companies in the world, best known for its fleet of advanced land rigs used to drill oil and gas wells in the United States, where it operates more rigs in the Permian Basin than any competitor in the Lower 48. It also runs international land rigs and a smaller set of offshore platform rigs and labor contracts. H&P does not own the oil and gas it helps produce; it earns fees from energy producers for supplying rigs, drilling technology, and crews, so its business is a service to the exploration-and-production industry.
CAJPY vs HP: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- CAJPY drivers: Imaging and network cameras; Semiconductor lithography and nanoimprint.
- HP drivers: US land-drilling leadership; International expansion and the Middle East.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Printing is in long-term structural decline as offices print less, so Canon must keep finding growth elsewhere to offset a segment that still produces over half its sales. For HP, the dominant risk is cyclicality: H&P's revenue depends on producers' drilling budgets, which rise and fall with oil and gas prices, so a downturn in energy prices can quickly cut rig demand, utilization, and day rates.
CAJPY or HP: which should you pick?
Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick CAJPY if you believe its drivers more; HP if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CAJPY and HP guides.
CAJPY vs HP: the full fundamentals
CAJPY. Canon trades at a low multiple relative to US hardware peers, reflecting low single-digit sales growth and the drag of a mature printing business that is more than half of revenue. The valuation case leans on cash returns: a ~40% payout target and repeated buybacks, including ¥100 billion in 2025 and ¥200 billion completed in September 2026, which together retire a few percent of the share count a year. Analyst targets on the Tokyo shares averaged around ¥4,800 in recent listings, modestly above the ~¥4,400 trading level. Figures are approximate and the dollar values move with the yen.
HP. At about $37 on October 16, 2026, H&P traded near 0.9x sales and 6.6x EV/EBITDA, with no trailing P/E because of the fiscal 2026 net loss and about 24x forward earnings on fiscal 2027 EPS estimates of about $1.56. As a cyclical oil-services company, its earnings swing between profit and loss with drilling activity, so valuation depends more on drilling budgets and the international ramp than on one quarter. Analysts' mean target was about $45, with UBS raising its target to $50 in October.
Headline figures (approximate, October 2026): CAJPY shows revenue (ttm) ~¥4.7 trillion (2026 guidance ~¥4.8 trillion), operating profit (2026 guidance) ~¥465 billion (~9.7% margin), net income (2026 guidance) ~¥340 billion, market cap ~$25 billion (ADR ~$29, 1 ADR = 1 share); HP shows revenue (ttm) ~$4.0 billion, revenue growth (latest quarter, year over year) ~flat (-0.6%), operating margin ~5%, net income (ttm) ~-$139 million (loss).
The bottom line: CAJPY vs HP
CAJPY and HP are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined CAJPY and HP exposure against your real portfolio. It is not an investment adviser.
Wondering how CAJPY or HP fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Investing in Canon Inc. with AI
Connect the broker you already use and ask Walnut's AI how CAJPY fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
What is the difference between CAJPY and HP?
+
Canon Inc. Helmerich & Payne, Inc. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is CAJPY or HP the better stock?
+
Neither is universally better. CAJPY is the larger incumbent; HP is the smaller challenger and looks pricier on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, CAJPY or HP?
+
On forward P/E (as of October 2026), CAJPY trades at 13.60x and HP at 24.05x, so CAJPY is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both CAJPY and HP?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of CAJPY vs HP?
+
CAJPY: Printing is in long-term structural decline as offices print less, so Canon must keep finding growth elsewhere to offset a segment that still produces over half its sales. The medical segment has suffered production disruptions and component shortages in 2026 and has historically earned thin margins (~5.6% in 2025) relative to the price Canon paid for Toshiba Medical. Higher memory chip prices, energy and materials costs linked to the Middle East situation and shifting US trade policy all pressure margins; Canon's 2026 plan includes ~¥35 billion of expected Middle East headwinds and ~¥6 billion from memory costs, offset by ~¥37.5 billion of tariff relief that may not recur. Competition is intense in every segment, from Sony in cameras to ASML and Nikon in lithography and Siemens Healthineers and GE HealthCare in medical. For CAJPY holders specifically, returns are earned in yen and converted to dollars, so a stronger yen can raise the ADR price while hurting Canon's reported profit, and vice versa; dividends are paid in yen, converted by the depositary (minus fees) and may be subject to Japanese withholding tax. The ADR trades over the counter rather than on an exchange, which can mean wider bid-ask spreads and less liquidity than the Tokyo shares. HP: The dominant risk is cyclicality: H&P's revenue depends on producers' drilling budgets, which rise and fall with oil and gas prices, so a downturn in energy prices can quickly cut rig demand, utilization, and day rates. Results have already shown the strain, with a trailing twelve-month net loss of about $139 million and an adjusted net loss in fiscal Q2 2026 driven by weaker North American activity and much higher costs to reactivate rigs in Saudi Arabia amid supply-chain disruptions tied to Middle East conflict. That exposes the integration and execution risk from the KCA Deutag expansion, plus geopolitical exposure in the region. International operations add currency, contract, and political risk. The energy transition is a longer-term overhang, since reduced fossil-fuel investment over time would shrink the drilling market. Rig fleets are capital-intensive, so idle rigs still carry costs, debt of about $1.9 billion against about $231 million of cash keeps leverage in focus, and the dividend, while long-standing, depends on cash flow that can be volatile through the cycle.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell CAJPY or HP; figures are approximate and dated (as of October 2026). Verify current data before investing.